Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interaction

Clinical Cancer Research

Volumn 2, Issue 7, 1996, Pages 1221-1229

  Prabhu, Nita S ^a   Blagosklonny, Mikhail V ^a   Zeng, Yi Xin ^a   Wu, Gen Sheng ^a   Waldman, Todd ^b   El Deiry, Wafik S ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ARTICLE; CANCER CELL; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; COLON CANCER; DNA DAMAGE; DNA SYNTHESIS; GENE ACTIVATION; GENE DELETION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS EXPRESSION; VIRUS RECOMBINATION;

ADENOVIRIDAE; APOPTOSIS; CDC2-CDC28 KINASES; CELL DIVISION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; MUTATION; ONCOGENE PROTEINS, VIRAL; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029889030     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutation in human cancers. Science (Washington DC), 253: 49-53, 1991.
2. Greenblatt, M. S., Bennett, W. P , Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
3. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer. Science (Washington DC), 266: 1821-1828, 1994.
4. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
5. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
6. Symonds, H., Krall, L , Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
7. Bedi, A , Pasricha, P. J., Akhtar, A. J., Barber, J. P , Bedi, G. C., Giardiello, F. M., Zehnbauer, B. A., Hamilton, S. R., and Jones, R. J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55: 1811-1816, 1995.
8. Miyashita, T., Krajewski, S., Krajewski, M., Wang, H. G., Lin, H. K., Hoffman, B., Lieberman, D., and Reed, J. C. Tumor suppressor p53 is a regulator of bcl-2 and box in gene expression in vitro and in vivo. Oncogene. 9: 1799-1805, 1994.
9. Zhan, Q., Fan, S., Bae, I., Guillouf, C., Lieberman, D. A., O'Connor, P. M., and Fornace, A. J., Jr. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene, 9: 3743-3751, 1994.
10. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W-W., Kruzel, E., and Radinsky, R. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol., 15. 3032-3040, 1995.
11. Caelles, C., Helmberg, A., and Karin, M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (Lond.), 370: 220-223, 1994.
12. El-Deiry, W. S., Tokino. T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D , Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
13. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
14. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
15. 1, arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
16. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J., and Reed, S. I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiationinduced G, arrest. Cell, 76: 1013-1024, 1994
17. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B., and Mercer. W. E. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res., 55: 668-674, 1995.
18. Cip1 in muscle and other terminally differentiating cells Science (Washington DC), 267: 1024-1027. 1995.
19. Halevy, O., Novitch, B. G . Spicer, D. B., Skapek, S X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
20. WAFI/CIPI expression in normal and neoplastic tissues. Cancer Res., 55: 2910-2919, 1995.
21. Tahara. H., Sato, E., Noda, A., and Ide, T. Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene, 10: 835-840, 1995.
22. Michieli, P., Chedid. M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
23. Stemman, R. A , Hoffman, B., Iro, A., Guillouf, C., Lieberman, D. A., and El-Houseini, M. E. Induction of p21(WAF1/CIP1) during differentiation. Oncogene, 9: 3389-3396, 1994.
24. Sheikh, M. S., Li, X-S., Chen, J-C., Shao. Z-M., Ordonez, J V., and Fontana, J. A. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene, 9: 3407-3415, 1994.
25. Jiang, H., Lin, J., Su, Z., Collart, F. R., Huberman. E., and Fisher, P B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53 Oncogene, 9: 3397-3406, 1994.
26. Elbendary, A., Berchuck, A., Davis, P., Havrilesky, L., Bast, R. C., Jr., Iglehart, D., and Marks, J. R. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth & Differ., 5: 1301-1307, 1994.
27. Datto, M. B., Li, Y., Panus, J. F., Howe, D J., Xiong. Y., and Wang, X. F. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl Acad, Sci. USA, 92: 5545-5549, 1995.
28. Reynisdottir, I., Polyak, K., Iavarone, A., and Massague. J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9: 1831-1845, 1995.
29. Harper, J. W., Elledge, S J., Keyomarsi, K., Dynlacht, B., Tsai, L-H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., Swindell, E., Fox, M. P., and Wei, N. Inhibition of cyclin-dependent kinases by P21. Mol. Biol. Cell, 6: 387-400. 1995.
30. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond ), 369: 574-578, 1994.
31. 1 checkpoint control. Cell. 82: 675-684, 1995.
32. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell, 71: 587-597, 1992.
33. Wu, G. S., and El-Deiry, W. S. Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or Bc12. Clin. Cancer Res., 2: 623-633, 1996.
34. 1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
35. Wilkinson, G. W. G., and Akrigg, A. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res., 20: 2233-2239, 1992.
36. Zhan, Q., El-Deiry, W., Bae, I., Alamo, I., Kastan, M. B., Vogelstein, B., and Fornace, A. J., Jr. Similarity of the DNA-damage responsiveness and growth suppressive properties of WAF1/CIP1 and GADD45. Int. J. Oncol., 6: 937-946, 1995.
37. VVAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 11: 1899-1905, 1995.
38. Waf is contained in its N-terminal half ("half-WAF"). Oncogene. 11: 393-395, 1995.
39. CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev., 9: 1740-1752, 1995.
40. Vogelstein, B.. and Kinzler, K. W. p53 function and dysfunction Cell, 70: 523-526, 1992.